current news

Murray Cairns 3
Huge step towards understanding the cause of schizophrenia

Just as no two people are the same, no two people with schizophrenia will present with precisely the same physical or neurobiological attributes. Some patients may have delusions and hallucinations; others will experience a decreased range of emotional affect, or cognitive deficits that disturb memory and language.

The key to understanding …

Why your support is essential

“With the success rates¬† of our national research project grant rounds from the National Health and Medical Research Council dropping every year, it is a real concern for researchers in the medical field to keep producing dynamic and cutting-edge research,” writes Dr Francesca Fernandez-Enright in the latest issue of International …

Canakinumab Add-on Treatment for Schizophrenia (CATS) Study

Volunteer call out: Canakinumab adjunctive treatment to reduce symptoms and improve cognition in people with schizophrenia displaying elevated blood inflammatory markers

What is the purpose of the study?

You are invited to participate in a research study of a human immune cell-line antibody upon language, memory, and symptoms of schizophrenia. This human …

A thank you, made just for you!

The Schizophrenia Research Institute has come a long way since 1996. Here are some of our biggest achievements, and some pretty convincing reasons to invest in schizophrenia research.

Thanks you to our scientists for the great work they do, and to our supporters. We couldn't have come this far without you!